Telix Pharmaceuticals Ltd
SEC CIK 2007191 · TLX · last insider filing 2026-05-18
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Gill David N | Director | filed 2026 - 2026 |
| Jellison William R | Director | filed 2026 - 2026 |
| Rivas Maria | Director | filed 2026 - 2026 |
| Behrenbruch Christian | Director · MD & Group CEO | filed 2026 - 2026 |
| Nelson Mark Alexander | Director | filed 2026 - 2026 |
| Mcdonald Marie Elizabeth | Director | filed 2026 - 2026 |
| Skinner Jann Elizabeth | Director | filed 2026 - 2026 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Smith Darren Charlton | Group Chief Financial Officer | filed 2026 - 2026 |
| Patti Darren Joel | Group Chief Operating Officer | filed 2026 - 2026 |
| Cade David Norman | Group Chief Medical Officer | filed 2026 - 2026 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.